HI homepage

Thumbnail

Similar tools could have great utility in enhancing clinical workflows and improving the diagnosis of cerebral aneurysms, which can be deadly if ruptured.

The iCardio.ai EchoMeasure AI software to automate measurements for cardiac echo imaging. It was FDA cleared in October 2024.

iCardio.ai, co-founded by a cardiologist, is part of the Cedars-Sinai Accelerator program. The startup has already announced new partnerships with Viz.ai, Abbott and others in the cardiac health space. 

Thumbnail

The heightened sensitivity of MRI is beneficial in that it allows for earlier detection of cancers, but it also presents challenges for providers tasked with managing patients’ care plans.

Such technology can be leveraged to improve risk assessments without accruing additional expenses for patients or clinicians, potentially filling in gaps where DXA exams fall short.

Around the web

iCardio.ai, co-founded by a cardiologist, is part of the Cedars-Sinai Accelerator program. The startup has already announced new partnerships with Viz.ai, Abbott and others in the cardiac health space. 

Four of the seven Medicare Administrative Contractors (MACs) announced they will now cover artificial intelligence-enabled quantitative coronary tomography (AI-QCT) and coronary plaque analysis (AI-CPA). 

Baxter’s North Cove manufacturing site was significantly impacted by unprecedented rain and storm surge from Hurricane Helene hitting western North Carolina.